National Breast Cancer Awareness Month
Breast Cancer Awareness Month (BCAM), also referred to in America as National Breast Cancer Awareness Month (NBCAM), is an annual international health campaign organized by major breast cancer charities every October to increase awareness of the disease and to raise funds for research into its cause, prevention, diagnosis, treatment and cure. The campaign also offers information and support to those affected by breast cancer.
Breast cancer awareness month is a yearly campaign that intend educate people about the importance of early screening, test and more. This campaign starts on October 1 and ends on October 31 every year.
NBCAM was founded in 1985 in October as a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries (now part of AstraZeneca, producer of several anti-breast cancer drugs). The aim of the NBCAM from the start has been to promote mammography as the most effective weapon in the fight against breast cancer. In 1993 Evelyn Lauder, Senior Corporate Vice President of the Estée Lauder Companies, founded The Breast Cancer Research Foundation and established the pink ribbon as its symbol, though this was not the first time the ribbon was used to symbolize breast cancer: a 68-year-old California woman named Charlotte Haley, whose sister, daughter, and granddaughter had breast cancer, had distributed peach-color ribbons to call attention to what she perceived as inadequate funding for research. In the fall of 1991, the Susan G. Komen Foundation had handed out pink ribbons to participants in its New York City race for breast cancer survivors.
In 2010, Delta Air Lines painted N845MH, a Boeing 767-432ER in "Breast Cancer Research Foundation" special colors. In September 2015, a newer version of the livery was repainted on the same plane.
First Breast Cancer Stamp
First Breast Cancer
Breast Cancer Semipostal Stamp issued 2014
The Breast Cancer Research semipostal stamp, originally issued in 1998. Mandated by Congress in 1997 and signed into law by President Bill Clinton, the 1998 Breast Cancer Research stamp was the first semipostal issued by the U.S. Postal Service®. Semipostals are stamps sold at a surcharge to raise money for a particular cause. Purchase of this stamp supports the Breast Cancer Research work of the National Institutes of Health and the Medical Research Program of the Department of Defense.
The stamp art depicts a woman standing with her right arm raised, reaching behind her head in the position recommended for breast self-examination. The drawing of the woman’s body is set against a background of pastel colors ranging from yellow to violet that cover the entire face of the stamp. Across the top of the stamp are the words “Breast Cancer.” Circling the figure’s right breast are the phrases, in all caps, “FUND THE FIGHT.” and “FIND A CURE.”
As of the end of August 2020, more than 1.06 billion Breast Cancer Research stamps had been sold, bringing the total revenue raised to more than $91.4 million. By law, 70 percent of the net amount raised is transferred to the National Institutes of Health and 30 percent is transferred to the Medical Research Program at the Department of Defense.
International Semipostal Stamps
International Stamp Images are from Cure Breast Cancer, Inc website